Lucid Diagnostics LUCD
NASDAQ LUCD
$0.83 -0.07 (-7.28%)
As of: Sep 9, 2026 · 2:33 PM EDT

Lucid Diagnostics (LUCD) Net Margin Growth (3y) (2024 - 2026)

Analysis

Lucid Diagnostics (LUCD) Net Margin Growth (3y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Natera 47.16 Bn 46.06 Bn 486.15 Mn 3,350.00
2 Labcorp Holdings 26.30 Bn 26.15 Bn 1.11 Bn 178.00
3 Quest Diagnostics 26.05 Bn 25.42 Bn 1.03 Bn 30.00
4 Guardant Health 21.87 Bn 20.81 Bn 219.03 Mn 1,719.00
5 Tempus AI 11.19 Bn 10.38 Bn 274.25 Mn 5,318.00
6 Caris Life Sciences 6.93 Bn 6.13 Bn 182.38 Mn -
7 Sotera Health 5.21 Bn 4.86 Bn 177.96 Mn 748.00
8 BillionToOne 4.73 Bn 4.18 Bn 77.11 Mn -
9 iRhythm Holdings 3.96 Bn 3.37 Bn 163.21 Mn 1,472.00
10 Lucid Diagnostics 152.27 Mn 118.86 Mn 55,000.00 617,686.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 617,686.00
Mar 31, 2026 182,529.00
Dec 31, 2025 1.22 Mn
Sep 30, 2025 1.80 Mn
Mar 31, 2025 214,206.00
Dec 31, 2024 280,451.00
Sep 30, 2024 242,295.00